Computer scientists develop a new AI tool that rivals AlphaFold 3 in mapping RNA
Peer-Reviewed Publication
This September, we're exploring the science behind vaccines. From how they train our immune systems to fight disease to the research shaping their future, vaccines offer an opportunity to discover the science helping protect individuals and communities around the world.
Updates every hour. Last Updated: 22-Oct-2026 21:16 ET (23-Oct-2026 01:16 GMT/UTC)
Scientists have shown that a drug commonly used to treat epilepsy could be repurposed to significantly boost the response to vaccines in humans, helping protect those for whom the vaccine is less effective, such as the elderly or immunocompromised.
POSTECH and Incheon National University develop mussel adhesive protein to achieve “sustained immunity,” offering a technology that could ease the burden of repeat vaccination.
A vaccine to treat what some call a "neglected disease" is showing promising results. Schistosomiasis primarily affects impoverished communities outside of the U.S. Hundreds of millions of people carry the disease. Still, there is only one drug available for treatment, and it doesn’t prevent reinfection. Now, research shows that at new vaccine called SchistoShield® can both treat and prevent this disease.
A vaccine to treat what some call a "neglected disease" is showing promising results. Schistosomiasis primarily affects impoverished communities outside of the U.S. Hundreds of millions of people carry the disease. Still, there is only one drug available for treatment, and it doesn’t prevent reinfection. Now, research shows that at new vaccine called SchistoShield® can both treat and prevent this disease.
Disease management is a significant aspect of aquaculture which is a vital industry that is a significant food source. One of the most serious threats is a disease caused by the nervous necrosis virus (NNV) which can wipe out large populations of farmed fish and cause major economic losses in the aquaculture industry.
To strengthen the aquaculture industry, National University of Singapore (NUS) scientists, together with researchers from the Temasek Life Sciences Laboratory, have developed a novel oral vaccine for fish that can protect them against NNV and be implemented in an effective, efficient and practical way to immunise large amounts of fish.A team of researchers from the Max Delbrück Center and the United Kingdom have shown in “Aging Cell” that the naturally occurring compound spermidine can help boost vaccine response in older adults by reducing molecular markers of immune system ageing.